Vinge advised Apotea on the deal. Apotea AB (publ) completed its listing on Nasdaq Stockholm. The offering price was SEK 58 per ordinary share, corresponding to a...
Apotea’s Listing on Nasdaq Stockholm
Blue Wolf Capital Partners’ Acquisition of Manufacturing and Development Facilities from Recipharm
Vinge advised Blue Wolf Capital Partners on the deal. Blue Wolf Capital Partners LLC, a middle market private equity firm specializing in the healthcare and industrial...
Axcel VI and Currentum’s Acquisition of Elektro-Emanuel
Vinge advised Axcel VI and the Currentum Group on the transaction. Axcel VI and the Currentum Group secured the acquisition of Elektro-Emanuel AB. Elektro-Emanuel AB...
Telko’s Acquisition of Swed Handling
Vinge advised Aspo on the deal. Telko expands its chemicals business in Sweden by acquiring Swed Handling, a leading Swedish chemical distributor, from TeRa Invest. As...
Sobro’s Investment in Clinton Marine Survey
Vinge advised Sobro on the deal. Clinton Marine Survey has chosen to broaden its ownership with Sobro as a new partner and majority shareholder. All existing...
Attendo’s Acquisition of Team Olivias Care Operations
Vinge advised Attendo on the deal. Attendo, the largest care company in the Nordic region, closed an agreement to acquire Team Olivia’s Swedish care operations (excluding...
EQT Healthcare Growth’s Acquisition of Mabtech
Vinge advised EQT Healthcare Growth on the deal. EQT Healthcare Growth, a new dedicated healthcare buy-out strategy introduced by EQT, completed the acquisition of the biotech...